-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Iio3aQrlYNI2MJ1B/VzailNBYaZ+SnPg4nxamUKqtn99eahjGLa9AfjaQJ6/lWV4 5rYb2MEaV5987/LhmPnxug== 0001428369-10-000002.txt : 20101208 0001428369-10-000002.hdr.sgml : 20101208 20101208164524 ACCESSION NUMBER: 0001428369-10-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20101208 DATE AS OF CHANGE: 20101208 EFFECTIVENESS DATE: 20101208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: THAR PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001428369 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-151589 FILM NUMBER: 101240253 BUSINESS ADDRESS: STREET 1: 730 WILLIAM PITT WAY CITY: PITTSBURGH STATE: PA ZIP: 15238 BUSINESS PHONE: 412-435-0200 MAIL ADDRESS: STREET 1: 730 WILLIAM PITT WAY CITY: PITTSBURGH STATE: PA ZIP: 15238 D 1 primary_doc.xml X0704 D LIVE 0001428369 THAR PHARMACEUTICALS INC 730 WILLIAM PITT WAY PITTSBURGH PA PENNSYLVANIA 15238 412-435-0200 DELAWARE None None Corporation true 2008 Raymond Houck c/o Thar Pharmaceuticals 730 William Pitt Way Pittsburgh PA PENNSYLVANIA 1523 Executive Officer Director Lalit Chordia c/o Thar Pharmaceuticals, Inc. 730 William Pitt Way Pittsburgh PA PENNSYLVANIA 15238 Director Philip Sussman c/o Thar Pharmaceuticals, Inc. 730 William Pitt Way Pittsburgh PA PENNSYLVANIA 15238 Director Filip Amram c/o Thar Pharmaceuticals, Inc. 730 William Pitt Way Pittsburgh PA PENNSYLVANIA 15238 Director Mazen Hanna c/o Thar Pharmaceuticals, Inc. 730 William Pitt Way Pittsburgh PA PENNSYLVANIA 15238 Executive Officer Director Jason Bablak c/o Thar Pharmaceuticals, Inc. 730 William Pitt Way Pittsburgh PA PENNSYLVANIA 15238 Executive Officer Brian Moyer c/o Thar Pharmaceuticals, Inc. 730 William Pitt Way Pittsburgh PA PENNSYLVANIA 15238 Executive Officer Pharmaceuticals Decline to Disclose 06 false 2010-11-29 false true true true false 100000 8092792 2025000 6067792 The total offering amount includes shares attributable to the sale of Series A-1 stock and warrants and the conversion of existing convertible debt. The final amount is subject to actual debt converted into shares and warrants exercised. false 5 0 0 796000 true A use of proceeds is working capital, which use includes salaries of executive officers. false THAR PHARMACEUTICALS INC Brian M Moyer Brian Moyer Vice President, Corporate Development 2010-12-08 -----END PRIVACY-ENHANCED MESSAGE-----